BL-M02D1

DRUG3 trials

Sponsors

Sichuan Baili Pharmaceutical Co., Ltd.

Conditions

Breast CancerLocally Advanced or Metastatic Digestive Tract TumorsNon-small Cell Lung CancerSolid Tumor

Phase 1

A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors

Active, not recruitingNCT05339685

Sichuan Baili Pharmaceutical Co., Ltd.Breast Cancer

Start: 2022-05-20End: 2025-12-31Updated: 2025-09-26

A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors or Other Solid Tumors

Active, not recruitingNCT05385692

Sichuan Baili Pharmaceutical Co., Ltd.Locally Advanced or Metastatic Digestive Tract Tumors, Solid Tumor

Start: 2022-06-01End: 2025-12-31Updated: 2025-09-26

A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer or Other Solid Tumors

Active, not recruitingNCT05949619

Sichuan Baili Pharmaceutical Co., Ltd.Non-small Cell Lung Cancer

Start: 2023-09-04End: 2025-12-31Updated: 2025-09-29